Matrix Lab gets USFDA nod for Lamotrigine Tablet

Matrix Laboratories has received a final approval from the US Food and Drug Administration (USFDA) to market Lamotrigine Tablet in strength of 25 mg, 100 mg, 150 mg and 200 mg.